1887

Abstract

Onychomycosis is a common adult human mycosis, and dermatophytes of the genera are the most common causative agent. Many antimycotic agents are safe and highly effective for the treatment of dermatophytosis, and are available for clinical practice. Successful treatment depends on the ability of antifungal drugs to eradicate the fungal isolates. The aim of this work was to determine the MICs of four antifungal drugs (fluconazole, itraconazole, terbinafine and griseofulvin) recognized for ungual dermatophytosis treatment caused by species, especially and . MICs were determined using a broth microdilution method in accordance with Clinical and Laboratory Standards Institute approved standard M38-A with some modifications, such as an incubation temperature of 28 °C, an incubation time of 7 days and inocula constituted of only microconidia. The results showed that the activities of terbinafine and itraconazole were significantly higher (MICs of <0.007–0.031 and 0.015–0.25 μg ml, respectively) than other tested agents. All isolates had reduced susceptibility to fluconazole (1–64 μg ml). The MIC of griseofulvin varied among strains (MICs of 0.062–1 μg ml). The parameters adopted to perform susceptibility testing of and to antifungal agents appeared to be suitable and reliable, and could contribute to the possible development of a standard protocol.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46542-0
2007-04-01
2020-01-27
Loading full text...

Full text loading...

/deliver/fulltext/jmm/56/4/514.html?itemId=/content/journal/jmm/10.1099/jmm.0.46542-0&mimeType=html&fmt=ahah

References

  1. Bradley, M. C., Leidich, S., Isham, N., Elewski, B. E. & Ghannoum, M. A. ( 1999; ). Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail. Mycoses 42, (Suppl. 2), 105–110.
    [Google Scholar]
  2. Clinical and Laboratory Standards Institute ( 2002; ). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, approved standard M38-A. Wayne, PA: Clinical and Laboratory Standards Institute.
  3. Develoux, M. ( 2001; ). Griseofulvin. Ann Dermatol Venereol 128, 1317–1325.
    [Google Scholar]
  4. El Fari, M., Tietz, H. J., Presber, W., Sterry, W. & Graser, Y. ( 1999; ). Development of an oligonucleotide probe specific for Trichophyton rubrum. Br J Dermatol 141, 240–245.[CrossRef]
    [Google Scholar]
  5. Evans, E. G. ( 2001; ). The rationale for combination therapy. Br J Dermatol 145, Suppl. 60. 9–13.[CrossRef]
    [Google Scholar]
  6. Favre, B., Hofbauer, B., Hildering, K. & Ryder, N. S. ( 2003; ). Comparison of in vitro activities of 17 antifungal drugs against a panel of 20 dermatophytes by using a microdilution assay. J Clin Microbiol 41, 4817–4819.[CrossRef]
    [Google Scholar]
  7. Fernández-Torres, B., Vázquez-Veiga, H., Llovo, X., Pereiro, M., Jr & Guarro, J. ( 2000; ). In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum. Chemotherapy 46, 390–394.[CrossRef]
    [Google Scholar]
  8. Fernández-Torres, B., Cabañes, F. J., Carrillo-Muñoz, A. J., Esteban, A., Inza, I., Abarca, L. & Guarro, J. ( 2002; ). Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol 40, 3999–4003.[CrossRef]
    [Google Scholar]
  9. Fernández-Torres, B., Carrillo, A. J., Martín, E., Del Palacio, A., Moore, M. K., Valverde, A. & Guarro, J. ( 2001; ). In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob Agents Chemother 45, 2524–2528.[CrossRef]
    [Google Scholar]
  10. Ghannoum, M. A., Chatuverdi, V., Espinel-Ingroff, A., Pfaller, M. A., Rinaldi, M. G., Lee-Yang, W. & Warnock, D. W. ( 2004; ). Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes. J Clin Microbiol 42, 2977–2979.[CrossRef]
    [Google Scholar]
  11. Goldstein, A. O., Smith, K. M., Ives, T. J. & Goldstein, B. ( 2000; ). Mycotic infections. Effective management of conditions involving the skin, hair and nails. Geriatrics 55, 40–42, 45–47, 51–52.
    [Google Scholar]
  12. Gupta, A. K. ( 2000; ). Onychomycosis in the elderly. Drugs Aging 16, 397–407.[CrossRef]
    [Google Scholar]
  13. Gupta, A. K. & Kohli, Y. ( 2003; ). In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes and in vitro evaluation of combination antifungal activity. Br J Dermatol 149, 296–305.[CrossRef]
    [Google Scholar]
  14. Korting, H. C., Ollert, M. & Abeck, D. ( 1995; ). Results of German multicenter study of antimicrobial susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes strains causing tinea unguium. Antimicrob Agents Chemother 39, 1206–1208.[CrossRef]
    [Google Scholar]
  15. Makimura, K., Mochizuki, T., Hasegawa, A., Uchida, K., Saito, H. & Yamaguchi, H. ( 1998; ). Phylogenetic classification of Trichophyton mentagrophytes complex strains based on DNA sequences of nuclear ribosomal internal transcribed spacer 1 regions. J Clin Microbiol 36, 2629–2633.
    [Google Scholar]
  16. Mukherjee, P. K., Leidich, S. D., Isham, N., Leitner, I., Ryder, N. S. & Ghannoum, M. A. ( 2003; ). Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob Agents Chemother 47, 82–86.[CrossRef]
    [Google Scholar]
  17. Norris, H. A., Elewski, B. E. & Ghannoum, M. A. ( 1999; ). Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method. J Am Acad Dermatol 40, S9–S13.[CrossRef]
    [Google Scholar]
  18. Pujol, I., Guarro, J., Llop, C., Soler, L. & Fernández-Ballart, J. ( 1996; ). Comparison study of broth macrodilution and microdilution antifungal susceptibility tests for the filamentous fungi. Antimicrob Agents Chemother 40, 2106–2110.
    [Google Scholar]
  19. Roberts, D. T., Taylor, W. D. & Boyle, J. ( 2003; ). Guidelines for treatment of onychomycosis. Br J Dermatol 148, 402–410.[CrossRef]
    [Google Scholar]
  20. Santos, D. A. & Hamdan, J. S. ( 2005; ). Evaluation of broth microdilution antifungal susceptibility testing conditions for Trichophyton rubrum. J Clin Microbiol 43, 1917–1920.[CrossRef]
    [Google Scholar]
  21. Santos, D. A., Barros, M. E. S. & Hamdan, J. S. ( 2006; ). Establishing a method of inoculum preparation for susceptibility testing of Trichophyton rubrum and Trichophyton mentagrophytes. J Clin Microbiol 44, 98–101.[CrossRef]
    [Google Scholar]
  22. Serrano-Martino, M. del C., Chávez-Caballero, M., Valverde-Conde, A., Claro, R. M., Pemán, J. & Martín-Mazuelos, E. ( 2003; ). In vitro activity of voriconazole and three other antifungal agents against dermatophytes. Enferm Infecc Microbiol Clin 21, 484–487.[CrossRef]
    [Google Scholar]
  23. Sigurgeirsson, B., Paul, C., Curran, D. & Evans, E. G. V. ( 2002; ). Prognostic factors of mycological cure following treatment of onychomycosis with oral antifungal agents. Br J Dermatol 147, 1241–1243.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46542-0
Loading
/content/journal/jmm/10.1099/jmm.0.46542-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error